Related Experiment Videos
[Corticosteroids and the risk of glaucoma]
L A A van Boxtel1, P L L J Hardus, W S Al Hassan
1Universitair Medisch Centrum Groningen, Postbus 30.001, 9700 RB Groningen.
Nederlands Tijdschrift Voor Geneeskunde
|November 25, 2005
Summary
Corticosteroids can cause glaucoma, a serious side effect leading to blindness. Regular eye examinations are crucial for patients using steroids, especially those with a family history of glaucoma.
Area of Science:
- Ophthalmology
- Endocrinology
Background:
- Corticosteroids are widely prescribed for various medical conditions.
- A significant adverse effect of corticosteroid use is the development of glaucoma.
- Glaucoma, a leading cause of blindness, is often diagnosed at advanced stages.
Observation:
- Three young patients (two female, aged 20 and 32; one male, aged 28) developed glaucoma.
- The glaucoma was directly linked to the topical application of steroids.
- This highlights a potential risk even in younger individuals with steroid use.
Findings:
- Topical steroid use can induce glaucoma.
- Early detection is critical as the condition may be asymptomatic until advanced stages.
- Risk factors include regular steroid use in or around the eye.
Implications:
- Annual eye examinations are recommended for patients with a family history of glaucoma using ocular or periocular steroids.
- Consider follow-up for patients with a family history of glaucoma using systemic steroids.
- All patients on regular steroid therapy should seek prompt ophthalmological consultation if visual disturbances arise.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...